Mitogenic activity and signaling mechanism of 2-(14,15-epoxyeicosatrienoyl) glycerol, a novel cytochrome P450 arachidonate metabolite

被引:29
作者
Chen, Jianchun
Chen, Jian-Kang
Falck, John R.
Anjaiah, Siddam
Capdevila, Jorge H.
Harris, Raymond C.
机构
[1] Vanderbilt Univ, Dept Med, Sch Med, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA
[3] Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA
关键词
D O I
10.1128/MCB.01482-06
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Arachidonic acid is an essential constituent of cell membranes that is esterified to the sn-2 position of glycerophospholipids and is released from selected phospholipid pools by tightly regulated phospholipase cleavage. Metabolism of the released arachidonic acid by the cytochrome P450 enzyme system (cP450) generates biologically active compounds, including epoxyeicosatrienoic acids (EETs) and hydroxyeicosatetraenoic acids. Here we report that 2-(14,15-epoxyeicosatrienoyl)glycerol (2-14,15-EG), a novel cP450 arachidonate metabolite produced in the kidney, is a potent mitogen for renal proximal tubule cells. This effect is mediated by activation of tumor necrosis factor alpha-converting enzyme (ADAM17), which cleaves membrane-bound transforming growth factor a (proTGF-alpha) and releases soluble TGF-alpha as a ligand that binds and activates epidermal growth factor receptor (EGFR). The present studies additionally demonstrate that the structurally related 14,15-EET stimulates release of soluble heparin-binding EGF-like growth factor as an EGFR ligand by activation of ADAM9, another member of the ADAM family. Thus, in addition to the characterization of 2-14,15-EG's mitogenic activity and signaling mechanism, our study provides the first example that two structurally related biologically active lipid mediators can activate different metalloproteinases and release different EGFR ligands in the same cell type to activate EGFR and stimulate cell proliferation.
引用
收藏
页码:3023 / 3034
页数:12
相关论文
共 70 条
[1]   DEVELOPMENT OF NA+-DEPENDENT HEXOSE-TRANSPORT IN A CULTURED LINE OF PORCINE KIDNEY-CELLS [J].
AMSLER, K ;
COOK, JS .
AMERICAN JOURNAL OF PHYSIOLOGY, 1982, 242 (01) :C94-C101
[2]   Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy [J].
Asakura, M ;
Kitakaze, M ;
Takashima, S ;
Liao, Y ;
Ishikura, F ;
Yoshinaka, T ;
Ohmoto, H ;
Node, K ;
Yoshino, K ;
Ishiguro, H ;
Asanuma, H ;
Sanada, S ;
Matsumura, Y ;
Takeda, H ;
Beppu, S ;
Tada, M ;
Hori, M ;
Higashiyama, S .
NATURE MEDICINE, 2002, 8 (01) :35-40
[3]   Adams: Key components in EGFR signalling and development [J].
Blobel, CP .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2005, 6 (01) :32-43
[4]   SEGMENTAL SYNTHESIS AND ACTIONS OF PROSTAGLANDINS ALONG THE NEPHRON [J].
BONVALET, JP ;
PRADELLES, P ;
FARMAN, N .
AMERICAN JOURNAL OF PHYSIOLOGY, 1987, 253 (03) :F377-F387
[5]   ROLE OF CYTOCHROME-P-450 EPOXYGENASE METABOLITES IN EGF SIGNALING IN RENAL PROXIMAL TUBULE [J].
BURNS, KD ;
CAPDEVILA, J ;
WEI, SZ ;
BREYER, MD ;
HOMMA, T ;
HARRIS, RC .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1995, 269 (04) :C831-C840
[6]   Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors [J].
Campbell, WB ;
Gebremedhin, D ;
Pratt, PF ;
Harder, DR .
CIRCULATION RESEARCH, 1996, 78 (03) :415-423
[7]   LIVER MICROSOMAL CYTOCHROME-P-450 AND THE OXIDATIVE-METABOLISM OF ARACHIDONIC-ACID [J].
CAPDEVILA, J ;
CHACOS, N ;
WERRINGLOER, J ;
PROUGH, RA ;
ESTABROOK, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (09) :5362-5366
[8]  
Capdevila JH, 2000, J LIPID RES, V41, P163
[9]  
CAPDEVILA JH, 1990, METHOD ENZYMOL, V187, P385
[10]  
CARPENTER G, 1990, J BIOL CHEM, V265, P7709